Metformin in Women With Type 2 Diabetes in Pregnancy Trial
Status:
Completed
Trial end date:
2019-06-05
Target enrollment:
Participant gender:
Summary
Insulin is the standard treatment for the management of type 2 diabetes in pregnancy, however
despite treatment with insulin, these women continue to face increased rates of adverse
maternal and fetal outcomes. The investigators hypothesize that metformin use, in addition to
treatment with insulin, will help with blood sugar control, lower the dose of insulin needed,
lower weight gain, and improve baby outcomes.
Phase:
Phase 3
Details
Lead Sponsor:
Mount Sinai Hospital, Canada
Collaborators:
Canadian Institutes of Health Research (CIHR) Sunnybrook Research Institute University Health Network, Toronto